Kuwait vs Small island developing States (SIDS): Proportion of the target population who received a 3rd dose of
Kuwait
96.0%
in 2024
Small island developing States (SIDS)
53.0%
in 2024
Kuwait rank
16th
Small island developing States (SIDS) rank
30th
Proportion of the target population who received a 3rd dose of over time
- Kuwait
- Small island developing States (SIDS)
How they compare
Kuwait currently reports 96.0% against 53.0% in Small island developing States (SIDS), a difference of 43.0%.
That makes Kuwait's figure about 1.8 times Small island developing States (SIDS)'s.
Across all 17 years both countries report, Kuwait has been ahead every year.
Kuwait ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 99.0% | 0.5% | 98.5% | Kuwait |
| 2010s | 97.0% | 18.2% | 78.8% | Kuwait |
| 2020s | 96.8% | 49.0% | 47.8% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Kuwait or Small island developing States (SIDS)?
- Kuwait, at 96.0% against 53.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Kuwait and Small island developing States (SIDS)?
- 43.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Small island developing States (SIDS)?
- 17 years are reported by both, from 2008 to 2024.
- How do Kuwait and Small island developing States (SIDS) rank globally for proportion of the target population who received a 3rd dose of?
- Kuwait ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.